Jyothy Labs Limited
NSE: JYOTHYLABHousehold Products
Share price
₹187.94
+0.89% close of 9 Oct 2026
Price-based ratios (P/B, dividend yield, EV/EBITDA) are as of 8 Oct 2026, the close above is 9 Oct 2026.
Business score
How strong the business is, in one number. The parts behind it are in Pro.
61
out of 100 · worked out 8 Oct 2026
Your ratios
The numbers you want to see first. Tap Edit to change them.
Market cap
₹6,954 Cr
P/E ratio
24.4
P/B ratio
4.3
ROCE
28.7%
ROE
22.4%
Dividend yield
1.8%
Price & valuation chart
How the share price and its valuation have moved. Hover over the chart to see any day. Prices as of the last close.
Answers
Simple answers to the questions investors ask most, from the company's own numbers.
How fast it has been growing
Sales grew 3.9% over the past year, and 11.8% a year over its longer record. Meanwhile what it keeps of every 100 rupees of sales improved from 10.8% to 13% over the last four years.
Whether it grew faster than its sector
It grew 11.8% a year against a sector median of 9.9% — 1.9 percentage points faster.
Room to re-rate, or risk of de-rating
At 24.2× earnings against a market that pays 23.9× across 2199 companies we can price. Its own industry sits at 43.1×, across 5 companies. It is against its own five-year median of 35.0×, the 7th percentile of its own range.
Whether growth justifies the valuation
Priced at 1.7 times its growth rate, on earnings growth of 14%.
| Profit growth | Price per ₹1 profit | Per 1% growth | |
|---|---|---|---|
| Jyothy Labs Limited — this one | 14%/yr | 24.2× | ₹1.7 |
| Hindustan Unilever | 14%/yr | 39.3× | ₹2.8 |
| ITC Limited | 3%/yr | 16.2× | ₹5.4 |
| Nestle India | — | 68.7× | — |
| Varun Beverages Limited | 24%/yr | 43.1× | ₹1.8 |
| Britannia Industries | 8%/yr | 43.8× | ₹5.5 |
Compared with companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
How it compares with its peers
Against companies across the whole Fast Moving Consumer Goods sector, it ranks 18 of 177 on returns, 67 of 173 on growth, 46 of 178 on margin. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
What makes it hard to beat — and is that still true?
A wide advantage: it earns 28.7% on capital, ahead of 90% of companies across its whole sector. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
Whether its growth pays for itself
Yes — Over the last five years it made ₹1712 crore of cash from the business, spent ₹171 crore on plant and equipment, and returned ₹869 crore to lenders and shareholders. And the profit is real: of every 100 rupees it reported over 12 years, about 130 arrived as cash (before interest, which is why it can exceed the profit). Its cash comes back more slowly than it used to: it went from being paid 3 days before it paid its own suppliers to waiting 15 days for its cash.
Profit reality check
Is the profit real cash? Simple checks on the accounts. Facts only, not advice.
9 of 9 checks clear · 100%
Latest result · Q1 FY27
What the last results showed. Whether management kept its word is in Pro.
Sales grew 8.1% but the profit margin roughly halved to 8.4% as input costs rose 30-35%.
Announced 12 Aug 2026 · Standalone · Unaudited
Revenue
₹773 Cr
Net profit
₹48 Cr
Net margin
6.2%
EPS
₹1.30
Earnings call transcript · 12 Aug 2026
Checklist before you investPRO
Points for and against, in one list.
Key numbers & peers
The main numbers grouped by topic, and how the company compares with similar ones.
Price
- Market cap
- ₹6,954 Cr
- Prev close
- ₹187.94
- 52w High
- ₹325
- 52w Low
- ₹180
- Enterprise value
- ₹6,189 Cr
- Beta
- 0.8
- Price CAGR 1y
- -38.0%
- Price CAGR 3y
- -19.0%
- Price CAGR 5y
- 3.0%
- Price CAGR 10y
- 1.0%
Ratios
- Return on assets
- 14.8%
- PEG ratio
- 1.7
- P/E ratio
- 24.4
- P/B ratio
- 4.3
- EV / EBITDA
- 15.8
- Industry P/E
- 21.1
- ROCE
- 28.7%
- ROCE 5y average
- 31.8%
- ROE
- 22.4%
- Debt / Equity
- 0.0
- Interest coverage
- 91.2
- Dividend yield
- 1.8%
- ROE 3y average
- 28.0%
- ROE last year
- 22.0%
Annual P&L
- Annual revenue
- ₹2,944 Cr
- Annual profit
- ₹333 Cr
- Operating margin
- 15.0%
- Net profit margin
- 11.3%
- EBITDA margin
- 15.3%
- Sales growth 3y
- 5.9%
- Sales growth 5y
- 9.3%
- Profit growth 3y
- 14.0%
- Profit growth 5y
- 9.0%
- EPS
- ₹9.1
- Sales growth TTM
- 4.0%
- Profit growth TTM
- -23.0%
- Dividend payout
- 39.0%
Quarter P&L
- Sales latest quarter
- ₹773 Cr
- Profit latest quarter
- ₹48 Cr
- YoY quarterly sales growth
- 2.9%
- YoY quarterly profit growth
- -50.5%
- OPM latest quarter
- 8.0%
Balance Sheet
- Book Value
- ₹42.9
- Face Value
- ₹1.0
- Total debt
- ₹52 Cr
- Total cash
- ₹310 Cr
- Borrowings
- ₹52 Cr
- Reserves / Equity
- 41.9
Cash Flow
- Operating cash flow
- ₹412 Cr
- Free cash flow
- ₹346 Cr
- FCF yield
- 4.9%
- Net cash flow
- -₹25 Cr
Shareholding
- Promoter holding
- 62.9%
- FII holding
- 12.1%
- DII holding
- 13.4%
- Public holding
- 11.6%
Peer comparison
| Company | Price ₹ | P/E | Mkt cap ₹ Cr | Div yield % | Profit qtr ₹ Cr | Profit var % | Sales qtr ₹ Cr | Sales var % | ROCE % |
|---|---|---|---|---|---|---|---|---|---|
| Jyothy Labs | 191.44 | 24.8 | 7,030 | 1.83 | 47.6 | -50.8 | 773.4 | 3.0 | 28.7 |
| Eveready Inds. | 320.50 | 14.7 | 2,330 | 0.78 | 37.0 | 2.5 | 407.7 | 9.0 | 17.2 |
| High Energy Bat. | 569.00 | 37.2 | 510 | 0.53 | -1.8 | -333.3 | 7.9 | -40.5 | 20.4 |
| Indo National | 316.05 | 237 | 1.19 | 2.0 | 109.8 | 116.1 | -2.8 | -5.5 | |
| Panasonic Energy | 238.15 | 26.0 | 179 | 0.82 | 1.7 | 97.6 | 63.5 | 9.5 | 9.5 |
| Pee Cee Cosma | 467.00 | 14.2 | 124 | 0.64 | 3.4 | 12.0 | 47.4 | 19.1 | 21.0 |
| Yuvraaj Hygiene | 9.09 | 18.2 | 82 | 0.00 | 1.9 | 175.7 | 16.2 | 113.6 | 29.8 |
| Median | 318.27 | 24.8 | 374 | 0.80 | 2.7 | 7.3 | 89.8 | 6.0 | 18.8 |
Competes with: Ambica Agarbathies & Aroma industries Limited, Eveready Industries India Limited, Indo-National Limited
Quarterly results
Sales and profit for each of the last 13 quarters. Newest on the right. ₹ crore.
| Line item | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 686 | 732 | 678 | 659 | 741 | 733 | 704 | 666 | 751 | 736 | 740 | 717 | 773 |
| Expenses | 569 | 596 | 558 | 551 | 608 | 595 | 588 | 554 | 627 | 618 | 629 | 621 | 709 |
| Material Cost | 311 | 354 | 384 | 354 | 380 | 530 | |||||||
| Change in Inventories | 7.07 | 17 | -30 | 13 | -6.38 | -75 | |||||||
| Purchases of Stock-in-Trade | 20 | 20 | 28 | 29 | 20 | 20 | |||||||
| Employee Cost | 78 | 87 | 85 | 85 | 85 | 88 | |||||||
| Other Expenses | 138 | 150 | 151 | 149 | 142 | 145 | |||||||
| Operating Profit | 118 | 135 | 119 | 108 | 134 | 138 | 116 | 112 | 124 | 118 | 111 | 97 | 65 |
| OPM % | 17 | 18 | 18 | 16 | 18 | 19 | 16 | 17 | 17 | 16 | 15 | 13 | 8 |
| Other Income | 17 | 13 | 11 | 13 | 14 | 13 | 14 | 12 | 19 | 17 | 15 | 16 | 18 |
| Exceptional items (within Other Income) | -3.70 | 0 | 0 | 0 | 0 | 0 | |||||||
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 12 | 12 | 13 | 13 | 13 | 14 | 14 | 15 | 15 | 15 | 16 | 16 | 16 |
| Profit before tax | 121 | 135 | 115 | 107 | 132 | 136 | 114 | 108 | 128 | 119 | 109 | 96 | 65 |
| Tax % | 21 | 23 | 21 | 27 | 23 | 23 | 23 | 28 | 24 | 26 | 26 | 29 | 27 |
| Net Profit | 96 | 104 | 91 | 78 | 102 | 105 | 87 | 77 | 97 | 88 | 81 | 68 | 48 |
| EPS in Rs | 2.62 | 2.84 | 2.48 | 2.13 | 2.77 | 2.86 | 2.38 | 2.10 | 2.64 | 2.39 | 2.21 | 1.84 | 1.30 |
| Diluted EPS in Rs | 2.10 | 2.64 | 2.39 | 2.21 | 1.84 | 1.30 |
Profit & loss
Yearly sales, costs and profit for 12 years, plus the last 12 months (TTM). ₹ crore.
| Line item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,438 | 1,542 | 1,632 | 1,626 | 1,769 | 1,665 | 1,885 | 2,193 | 2,482 | 2,754 | 2,844 | 2,944 | 2,966 |
| Expenses | 1,271 | 1,313 | 1,371 | 1,362 | 1,483 | 1,415 | 1,568 | 1,945 | 2,166 | 2,274 | 2,344 | 2,494 | 2,576 |
| Material Cost | 1,358 | 1,471 | |||||||||||
| Change in Inventories | -18 | -6.42 | |||||||||||
| Purchases of Stock-in-Trade | 77 | 98 | |||||||||||
| Employee Cost | 325 | 341 | |||||||||||
| Other Expenses | 601 | 591 | |||||||||||
| Operating Profit | 166 | 229 | 261 | 264 | 286 | 250 | 317 | 248 | 316 | 480 | 500 | 450 | 390 |
| OPM % | 12 | 15 | 16 | 16 | 16 | 15 | 17 | 11 | 13 | 17 | 18 | 15 | 13 |
| Other Income | 63 | 15 | 11 | 43 | 27 | 16 | -4 | 18 | 47 | 54 | 51 | 67 | 66 |
| Exceptional items (within Other Income) | -3.70 | 0 | |||||||||||
| Interest | 12 | 56 | 51 | 42 | 28 | 25 | 12 | 12 | 13 | 5 | 6 | 4.99 | 5 |
| Depreciation | 70 | 54 | 55 | 57 | 58 | 76 | 78 | 89 | 50 | 50 | 56 | 61 | 63 |
| Profit before tax | 147 | 133 | 166 | 208 | 228 | 166 | 223 | 166 | 299 | 479 | 490 | 451 | 389 |
| Tax % | 3 | 44 | -22 | 23 | 15 | 5 | 15 | 16 | 20 | 23 | 24 | 26 | |
| Net Profit | 143 | 75 | 202 | 161 | 193 | 158 | 190 | 139 | 240 | 370 | 371 | 333 | 284 |
| EPS in Rs | 3.94 | 2.06 | 5.56 | 4.42 | 5.26 | 4.29 | 5.18 | 3.78 | 6.52 | 10 | 10 | 9.07 | 7.74 |
| Diluted EPS in Rs | 10 | 9.07 | |||||||||||
| Dividend Payout % | 51 | 122 | 54 | 6 | 57 | 70 | 77 | 66 | 46 | 35 | 35 | 39 |
Compounded growth
Average yearly growth over different spans, as stored. A span can cross a demerger or an acquisition.
Compounded sales growth
- 10 years
- 7%
- 5 years
- 9%
- 3 years
- 6%
- TTM
- 4%
Compounded profit growth
- 10 years
- 16%
- 5 years
- 9%
- 3 years
- 14%
- TTM
- -23%
Stock price CAGR
- 10 years
- 1%
- 5 years
- 3%
- 3 years
- -19%
- 1 year
- -38%
Return on equity
- 10 years
- 26%
- 5 years
- 26%
- 3 years
- 28%
- Last year
- 22%
Balance sheet
What the company owns and what it owes, at the end of each year. ₹ crore.
| Line item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 18 | 18 | 18 | 18 | 37 | 37 | 37 | 37 | 37 | 37 | 37 | 37 |
| Reserves | 944 | 454 | 635 | 665 | 817 | 707 | 897 | 696 | 845 | 1,105 | 1,346 | 1,552 |
| Borrowings | 519 | 402 | 451 | 479 | 217 | 221 | 97 | 171 | 47 | 51 | 61 | 52 |
| Other Liabilities | 436 | 460 | 255 | 297 | 341 | 325 | 393 | 448 | 464 | 540 | 580 | 612 |
| Total Liabilities | 1,916 | 1,334 | 1,360 | 1,459 | 1,412 | 1,289 | 1,424 | 1,352 | 1,392 | 1,732 | 2,024 | 2,252 |
| Fixed Assets | 570 | 538 | 542 | 489 | 471 | 484 | 457 | 440 | 435 | 444 | 460 | 504 |
| CWIP | 5 | 8 | 8 | 15 | 14 | 24 | 10 | 8 | 15 | 13 | 22 | 10 |
| Investments | 409 | 205 | 154 | 246 | 242 | 139 | 141 | 6 | 6 | 197 | 456 | 506 |
| Other Assets | 932 | 583 | 656 | 709 | 685 | 642 | 815 | 898 | 936 | 1,077 | 1,085 | 1,232 |
| Total Assets | 1,916 | 1,334 | 1,360 | 1,459 | 1,412 | 1,289 | 1,424 | 1,352 | 1,392 | 1,732 | 2,024 | 2,252 |
Cash flows
Real money coming in and going out each year — from the business, from investments and from loans. ₹ crore.
| Line item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 158 | 195 | 166 | 251 | 305 | 165 | 408 | 201 | 329 | 458 | 312 | 412 |
| Cash from Investing Activity | -0 | 97 | -20 | -81 | 25 | 72 | -149 | -29 | -48 | -344 | -161 | -277 |
| Cash from Financing Activity | -54 | -300 | -127 | -149 | -316 | -297 | -196 | -166 | -251 | -135 | -157 | -160 |
| Net Cash Flow | 103 | -7 | 18 | 21 | 13 | -60 | 63 | 6 | 30 | -21 | -7 | -25 |
| Free Cash Flow | 153 | 172 | 110 | 257 | 267 | 126 | 384 | 180 | 317 | 444 | 254 | 346 |
Ratios
How fast customers pay, how long stock sits, and how well capital earns — year by year.
| Line item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 13 | 21 | 25 | 35 | 31 | 26 | 17 | 23 | 19 | 26 | 35 | 32 |
| Inventory Days | 87 | 81 | 80 | 79 | 76 | 91 | 101 | 84 | 76 | 73 | 84 | 80 |
| Days Payable | 62 | 69 | 60 | 62 | 66 | 52 | 69 | 67 | 55 | 72 | 75 | 74 |
| Cash Conversion Cycle | 38 | 33 | 46 | 52 | 40 | 65 | 48 | 40 | 41 | 28 | 45 | 38 |
| Working Capital Days | -33 | -108 | -77 | -77 | -20 | -9 | 9 | -3 | 12 | 39 | 39 | 15 |
| ROCE % | 11 | 16 | 22 | 20 | 23 | 19 | 26 | 18 | 31 | 44 | 37 | 29 |
Price trend
The price as a Renko brick chart: small moves drop out so the bigger path stands out.
Every brick is the same size, about one typical day's move. A new brick needs a full brick's move; turning the other way needs two. Bricks show where the price went, not where it will go.
Open interestPRO
Where option traders are positioned on this stock.
Industry numbers
The numbers that matter most in this industry, from the company's own filings.
1 when an audit qualification is filed as repetitive
0.00flag
2026-03-31
the company's own unlisted debt securities in default at period end
0.00cr
2026-06-30
the company's own loans / revolving facilities in default at period end (standalone filing)
0.00cr
2026-06-30
net debt from the filed balance sheet at the newest year end: Borrowings − Cash Equivalents − Investments (Current); negative = net cash
-764inr_cr
2026-03-31
guarantees / comfort given for promoter, promoter group, directors and KMP
0.00cr
2026-03-31
loans outstanding to promoter, promoter group, directors and KMP (governance filing)
0.00cr
2026-03-31
security given for the borrowing of promoter, promoter group, directors and KMP
0.00cr
2026-03-31
FY revenue / permanent employees + workers, same basis (calc)
99,19,137inr
2026-03-31
volume growth %
5.30pct
2026-06-30
News
News and filings about Jyothy Labs Limited. Open one to see why it matters.
No recent news for this company.
Supply chain
Who it buys from, sells to and competes with — as recorded in our map of company links.
Competes with
Uses as raw material
- PET (bottles / packaging)
- kraft paper / cartons (packaging)
- linear alkyl benzene (LAB) — detergent surfactant
- palm kernel oil / palm fatty acid derivatives (soap & surfactant)
- polypropylene (packaging)
Depends on the price of
- Crude Oil Brent
- Palm Oil
- caustic_soda
Buys from
- JHS Svendgaard Laboratories Limited · private-label oral-care / FMCG contract manufacturing
- Orient Technologies Limited · IT infrastructure & end-user computing solutions
- Pioneer Investcorp Limited · debt syndication & advisory mandate — refinancing (PINC IB deck select transactions)
- Shree Vasu Logistics Limited · CFA, warehousing & 3PL logistics services
- Tamilnadu PetroProducts Limited · Linear Alkyl Benzene (LAB) surfactant feedstock
About
What the company is, from our own records: where it sits, where it makes things, and what it is made of.
- Sector
- Fast Moving Consumer Goods
- Industry
- Household Products
- Classification
- Fast Moving Consumer Goods › Household Products
- ISIN
- INE668F01031
Business segments
- Fabric Care · 46%
- Dishwashing · 33%
- Personal Care · 11%
- Household Insecticides · 7%
- Others · 4%
Plants
- Bishnupur (Ujala Unit) · Bishnupur, West Bengal
- Doddaballapura Unit · Doddaballapura, Karnataka
- Guwahati Detergent Unit · Guwahati, Assam
- Guwahati Unit I · Amingaon / Guwahati, Assam
- Guwahati Unit II · Amingaon / Guwahati, Assam
- Guwahati Unit III · North Guwahati, Assam
- Guwahati Unit IV · North Guwahati, Assam
- Guwahati Unit V · Changsari, Assam
- Jammu Unit I and II · Bari Brahmana, Jammu & Kashmir
- Kalingamalai Unit · Villupuram district, Tamil Nadu
- Kandanassery Unit · Kandanassery / Ariyannur, Kerala
- Kankaria Railway Coaching Yard Unit · Ahmedabad, Gujarat
- Karaikal Unit · Karaikal, Puducherry
- Mehboobnagar Unit · Kothur, Telangana
- Pithampur (Maxo & Exo Unit) · Pithampur, Madhya Pradesh
- Puducherry (Detergent, Exo, Maxo Unit) · Suthukeny, Puducherry
- Puducherry (PCD, Floorshine) · Suthukeny, Puducherry
- Puducherry (Ujala & Bottle) · Suthukeny, Puducherry
- Silvassa Engineering Division (EDS) · Silvassa, Dadra & Nagar Haveli
- Silvassa Unit II · Silvassa, Dadra & Nagar Haveli
News impact
Big market events that reach Jyothy Labs Limited, and how the effect spreads.
22 Jun, 04:29 IST · Market event · medium impact
Jyothy Labs to expand Exo into broader dishwash franchise after Henkel brands exit portfolio
Who it hits first
- Jyothy loses Henkel-brand revenue but gains Exo expansion runway
Who may gain
- Jyothy long-term margin (own brand vs licensed)
Along the supply chain
Downstream
Consumers continue to demand dishwash category
Upstream
Surfactants, packaging, distribution unchanged
Where demand moves
Business
Dishwash demand routes to Exo (own brand) instead of Henkel licensed brands
Capital
Capital cautious on near-term transition
How it spreads across sectors
FMCG
Modest sector signal — own-brand strategy validation
When it plays out
Immediate
Limited impact
Medium term
Own-brand margin lift
Short term
Q1-Q2 transition revenue gap
12 May, 20:53 IST · Market event · high impact
Jyothy Labs shares -15% over 2 days as Henkel ends Pril (dishwash) & Fa (deodorant) licence agreements
Who it hits first
- Jyothy Labs -15% in 2 days on Henkel licence termination
- 10% revenue at risk over transition period
- Margin pressure as company invests in own-brand rebuild
Who may gain
- HUL (Vim dishwash) — primary share-gainer
- Godrej Consumer (deodorant segment)
- RSPL / private label dishwash
Along the supply chain
Downstream
FMCG distributors face brand swap costs; modern trade negotiations
Upstream
Surfactant suppliers (Galaxy Surfactants, Pidilite chemicals) — no immediate impact, demand transitions to Vim/Exo
Where demand moves
Business
Pril/Fa shelf space + consumer wallet share flows to HUL (Vim) and lesser to Godrej; Jyothy must rebuild brands
Capital
Within FMCG mid-caps, rotation away from Jyothy to large-cap defensives (HUL, ITC); reinforces 'large-cap FMCG > mid-cap FMCG' positioning
How it spreads across sectors
Fast Moving Consumer Goods
Reinforces preference for own-brand FMCG models; licence-driven mid-caps de-rate
When it plays out
Immediate
Jyothy already down 15% — further 5-10% downside as Q4 results detail transition costs
Medium term
12-18 months: Either Exo gains traction (rerate) or share loss confirmed (further derate)
Short term
Q1-Q2 FY27 margin compression as Exo relaunch absorbs costs
Dividends, splits & big trades
Money paid out, share splits and buybacks, and big buys or sells by funds and insiders.
Dividends
| 29 Jun 2026 | unspecified | ₹3.5 |
|---|---|---|
| 28 Aug 2025 | unspecified | ₹3.5 |
| 3 Jul 2024 | unspecified | ₹3.5 |
| 3 Jul 2023 | unspecified | ₹3 |
| 1 Jul 2022 | unspecified | ₹2.5 |
| 20 Jul 2021 | unspecified | ₹4 |
| 19 Mar 2020 | interim | ₹3 |
| 12 Jul 2019 | unspecified | ₹3 |
Splits, bonuses & buybacks
- daily-prices repair: 9 rows from NSE's archive (replace 1, delete 1, insert 7), 2016-10-30..2026-02-01 (docs/flat_day_repair.md)1× · 30 Oct 2016
Documents
Annual reports, results presentations and earnings calls, straight from the source.
- Earnings call · Q1FY2712 Aug 2026
- Results presentation30 Jun 2026
- Annual report · 2025-2619 Jun 2026
- Earnings call · Q4FY264 May 2026
- Earnings call · Q3FY269 Feb 2026
Facts from company filings and exchange data. Not investment advice: nothing here tells you to buy or sell.